Stathmin 1 (STMN1), also known as p17, p18, p19, 19K, metablastin, oncoprotein 18, LAP
18 and Op18, is a 19 kDa cytosolic protein. It was the first discovered member of a family of …

Full article: Stathmin 1: a protein with many tasks. New biomarker and potential target in
cancer Skip to Main Content Taylor and Francis Online homepage Taylor and Francis Online …

Abstract The oncoprotein stathmin 1 (STMN1) is upregulated in most, if not all, cancers of
epithelial cell origin; therefore STMN1 is considered a target for cancer therapy. However, its …

In previous studies, we demonstrated that miR-193b expression is reduced in melanoma
relative to benign nevi, and also that miR-193b represses cyclin D1 and Mcl-1 expression …

Abstract Stathmin 1 (STMN1), a major microtubule-depolymerizing protein, is involved in cell
cycle progression and cell motility. However, the clinical significance of STMN1 expression …

Frequent intrahepatic metastasis causes early tumor recurrence and dismaying prognosis of
human hepatocellular carcinoma (HCC). We recently identified overexpression of stathmin1 …

Background: Stathmin1 (STMN1) is a cytosolic phosphoprotein that regulates cellular
microtubule dynamics and is known to have oncogenic activity. Despite several reports, its …

Introduction: Stathmin is a microtubule-destabilizing phosphoprotein, firstly identified as the
downstream target of many signal transduction pathways. Several studies then indicated …

Abstract Stathmin1 (STMN1) regulates progression in various cancers. The present study
aimed to determine the relationship between STMN1 expression and several cancer-related …

Stathmin1 (STMN1) is a candidate oncoprotein and prognosis marker in several kinds of
cancers. This study was aimed to analyze its expression and biological functions in gastric …